Turn Therapeutics Inc.
TTRX • Biotechnology
$9.80
▼ -0.27 (-2.68%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 54%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$288.86M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Weak liquidity · 0.87Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$9.80
Change-2.68%
Shares Out29.48M
Market Cap$288.86M
Enterprise Value$283.63M
52W Range2.57 - 26.50
Beta2.10
P/E-75.29
P/B47.22
P/FCF-71.10
EV/EBITDA-42.48
EV/FCF-69.81
Price$9.80
Change-2.68%
Shares Out29.48M
Market Cap$288.86M
Enterprise Value$283.63M
52W Range2.57 - 26.50
Beta2.10
P/E-75.29
P/B47.22
P/FCF-71.10
EV/EBITDA-42.48
EV/FCF-69.81
Earnings Yield-1.33%
FCF Yield-1.41%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio0.87
Quick Ratio0.87
Volume63.75K
Avg Volume64.45K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
26
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
49/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.02Weak liquidity · 0.87Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
🧾
No insider activity
No recent insider transactions available.